Arecor Therapeutics plc (ARECOR THERAPEUTICS PLC ORD GBP) aktie
AREC.L
Fördröjd 15 min£68.00+2.00 (+3.03%)
Laddar diagram...
ARECOR THERAPEUTICS PLC ORD GBP
Market Cap
$25,674,488
Öppning68.00
Högsta68.00
Lägsta68.00
Volym10k
P/E34.00
Börsvärde25.67M
52 veckors högsta100.00
52 veckors lägsta41.00
Genomsnittlig volym16.75k
UtdelningN/A
Beta-0.21
EPS0.02
Om Arecor Therapeutics plc (ARECOR THERAPEUTICS PLC ORD GBP) aktie
Arecor Therapeutics plc, a clinical stage biotechnology company, develops therapeutics that address diabetes, obesity and other cardiometabolic diseases in the United Kingdom. The company's lead therapeutic product is the AT278, a disruptor insulin which is designed to transform Automated Insulin Delivery (AID) systems to improve patient care for people living with diabetes. It also develops a novel oral delivery platform using a GLP-1 receptor agonist. Arecor Therapeutics plc was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.
Företagsinformation
Börs: LSE (LSE)
Sektor: Sundhed
Industri: Bioteknologi
Adress:
Chesterford Research Park
CB10 1XL Little Chesterford, United Kingdom
CB10 1XL Little Chesterford, United Kingdom
Telefon: + 44 1223 426 060
Hemsida: https://arecor.com
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.
Lägsta kursmål
251.00
↑ 269.1%
Genomsnittligt kursmål
275.50
↑ 305.1%
Median kursmål
275.50
↑ 305.1%
Högsta kursmål
300.00
↑ 341.2%